Erik A. A. Wallén

1.2k total citations
46 papers, 1.1k citations indexed

About

Erik A. A. Wallén is a scholar working on Oncology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Erik A. A. Wallén has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 19 papers in Organic Chemistry and 18 papers in Molecular Biology. Recurrent topics in Erik A. A. Wallén's work include Peptidase Inhibition and Analysis (23 papers), Neuropeptides and Animal Physiology (12 papers) and Chemical Synthesis and Analysis (8 papers). Erik A. A. Wallén is often cited by papers focused on Peptidase Inhibition and Analysis (23 papers), Neuropeptides and Animal Physiology (12 papers) and Chemical Synthesis and Analysis (8 papers). Erik A. A. Wallén collaborates with scholars based in Finland, Sweden and United Kingdom. Erik A. A. Wallén's co-authors include Elina M. Jarho, Pekka T. Männistö, Jarkko I. Venäläinen, Kristina Luthman, Jukka Gynther, Markus Forsberg, Johannes A. M. Christiaans, Antti Poso, Morten Grøtli and Maija Lahtela‐Kakkonen and has published in prestigious journals such as Biochemical Journal, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Erik A. A. Wallén

46 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik A. A. Wallén Finland 20 450 437 395 231 154 46 1.1k
Rita Scarpelli Italy 25 1.0k 2.2× 600 1.4× 519 1.3× 129 0.6× 23 0.1× 48 2.0k
Kenneth M. Lum United States 13 985 2.2× 519 1.2× 279 0.7× 55 0.2× 15 0.1× 20 1.5k
Russell J. Thomas Italy 14 293 0.7× 364 0.8× 98 0.2× 46 0.2× 274 1.8× 19 879
О.А. Бунеева Russia 18 610 1.4× 128 0.3× 84 0.2× 162 0.7× 16 0.1× 90 1.0k
Ashraf Khalil Qatar 17 641 1.4× 340 0.8× 206 0.5× 113 0.5× 8 0.1× 37 1.2k
Satyamaheshwar Peddibhotla United States 15 498 1.1× 755 1.7× 71 0.2× 227 1.0× 16 0.1× 30 1.3k
Jens‐Uwe Peters Switzerland 17 737 1.6× 328 0.8× 204 0.5× 355 1.5× 7 0.0× 38 1.3k
Paolo Di Fruscia United Kingdom 10 332 0.7× 352 0.8× 115 0.3× 29 0.1× 350 2.3× 15 980
Alex S. Kiselyov Russia 22 856 1.9× 759 1.7× 152 0.4× 56 0.2× 14 0.1× 53 1.6k
Mahadevan Lakshminarasimhan United States 14 577 1.3× 62 0.1× 142 0.4× 85 0.4× 497 3.2× 16 1.2k

Countries citing papers authored by Erik A. A. Wallén

Since Specialization
Citations

This map shows the geographic impact of Erik A. A. Wallén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik A. A. Wallén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik A. A. Wallén more than expected).

Fields of papers citing papers by Erik A. A. Wallén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik A. A. Wallén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik A. A. Wallén. The network helps show where Erik A. A. Wallén may publish in the future.

Co-authorship network of co-authors of Erik A. A. Wallén

This figure shows the co-authorship network connecting the top 25 collaborators of Erik A. A. Wallén. A scholar is included among the top collaborators of Erik A. A. Wallén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik A. A. Wallén. Erik A. A. Wallén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Turku, Ainoleena, et al.. (2023). Azulene as a biphenyl mimetic in orexin/hypocretin receptor agonists. Bioorganic & Medicinal Chemistry. 88-89. 117325–117325. 1 indexed citations
2.
Lahtela‐Kakkonen, Maija, et al.. (2021). 2-Imidazole as a Substitute for the Electrophilic Group Gives Highly Potent Prolyl Oligopeptidase Inhibitors. ACS Medicinal Chemistry Letters. 12(10). 1578–1584. 6 indexed citations
3.
Turku, Ainoleena, et al.. (2018). Pharmacological characterization of the orexin/hypocretin receptor agonist Nag 26. European Journal of Pharmacology. 837. 137–144. 12 indexed citations
4.
Weisell, Janne, et al.. (2018). Stapled truncated orexin peptides as orexin receptor agonists. Peptides. 102. 54–60. 8 indexed citations
5.
Fridén‐Saxin, Maria, Tina Seifert, Marcus Malo, et al.. (2016). Chroman-4-one and chromone based somatostatin β-turn mimetics. European Journal of Medicinal Chemistry. 114. 59–64. 12 indexed citations
6.
Kallionpää, Roope A., Susanne Bäck, Mirkka Sarparanta, et al.. (2014). Synthesis and biological evaluation of novel 123I-labeled 4-(4-iodophenyl)butanoyl-l-prolyl-(2S)-pyrrolidines for imaging prolyl oligopeptidase in vivo. European Journal of Medicinal Chemistry. 79. 436–445. 2 indexed citations
7.
Dyrager, Christine, Malin Wickström, Maria Fridén‐Saxin, et al.. (2011). Inhibitors and promoters of tubulin polymerization: Synthesis and biological evaluation of chalcones and related dienones as potential anticancer agents. Bioorganic & Medicinal Chemistry. 19(8). 2659–2665. 61 indexed citations
8.
Luthman, Kristina, et al.. (2010). Synthesis of Orthogonally Protected Disulfide Bridge Mimetics. The Journal of Organic Chemistry. 76(2). 673–675. 11 indexed citations
9.
Suuronen, Tiina, Erik A. A. Wallén, Jukka Leppänen, et al.. (2009). Nϵ-Thioacetyl-Lysine-Containing Tri-, Tetra-, and Pentapeptides as SIRT1 and SIRT2 Inhibitors. Journal of Medicinal Chemistry. 52(7). 2153–2156. 44 indexed citations
10.
Weisell, Janne, Can Hekim, Jouko Vepsäläinen, et al.. (2009). Mimetics of the disulfide bridge between the N- and C-terminal cysteines of the KLK3-stimulating peptide B-2. Amino Acids. 39(1). 233–242. 11 indexed citations
11.
Leppänen, Jukka, Valtteri Rinne, Sergiy Kyrylenko, et al.. (2008). Characterization of the binding properties of SIRT2 inhibitors with a N-(3-phenylpropenoyl)-glycine tryptamide backbone. Bioorganic & Medicinal Chemistry. 16(17). 8054–8062. 20 indexed citations
12.
Suuronen, Tiina, Valtteri Rinne, Carsten Wittekindt, et al.. (2008). Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 Inhibitors. Journal of Medicinal Chemistry. 51(15). 4377–4380. 66 indexed citations
13.
Leppänen, Jukka, Valtteri Rinne, Tiina Suuronen, et al.. (2007). N-(3-(4-Hydroxyphenyl)-propenoyl)-amino acid tryptamides as SIRT2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(9). 2448–2451. 42 indexed citations
14.
Jarho, Elina M., Jarkko I. Venäläinen, Jouko Vepsäläinen, et al.. (2006). An introduction of a pyridine group into the structure of prolyl oligopeptidase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(21). 5590–5593. 8 indexed citations
15.
Wallén, Erik A. A., et al.. (2006). Synthesis of 2,3,6,8-Tetrasubstituted Chromone Scaffolds. The Journal of Organic Chemistry. 71(18). 6863–6871. 49 indexed citations
16.
Venäläinen, Jarkko I., J. Arturo García‐Horsman, Markus Forsberg, et al.. (2006). Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitors. Biochemical Pharmacology. 71(5). 683–692. 60 indexed citations
17.
Jalkanen, Aaro J., Katja A. Puttonen, Jarkko I. Venäläinen, et al.. (2006). Beneficial Effect of Prolyl Oligopeptidase Inhibition on Spatial Memory in Young but Not in Old Scopolamine‐Treated Rats. Basic & Clinical Pharmacology & Toxicology. 100(2). 132–138. 41 indexed citations
18.
Venäläinen, Jarkko I., Erik A. A. Wallén, Antti Poso, J. Arturo García‐Horsman, & Pekka T. Männistö. (2005). Synthesis and Characterization of the Novel Fluorescent Prolyl Oligopeptidase Inhibitor 4-Fluoresceinthiocarbamoyl- 6-aminocaproyl-l-prolyl-2(S)-(Hydroxy- acetyl)pyrrolidine. Journal of Medicinal Chemistry. 48(23). 7093–7095. 8 indexed citations
19.
Venäläinen, Jarkko I., Risto O. Juvonen, Markus Forsberg, et al.. (2002). Substrate-dependent, non-hyperbolic kinetics of pig brain prolyl oligopeptidase and its tight binding inhibition by JTP-4819. Biochemical Pharmacology. 64(3). 463–471. 51 indexed citations
20.
Wallén, Erik A. A., Johannes A. M. Christiaans, Susanna M. Saario, et al.. (2002). 4-Phenylbutanoyl-2(S)-acylpyrrolidines and 4-phenylbutanoyl-l-prolyl-2(S)-acylpyrrolidines as prolyl oligopeptidase inhibitors. Bioorganic & Medicinal Chemistry. 10(7). 2199–2206. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rita Scarpelli Breakdown of academic impact, for papers by Kenneth M. Lum Breakdown of academic impact, for papers by Russell J. Thomas Breakdown of academic impact, for papers by О.А. Бунеева Breakdown of academic impact, for papers by Ashraf Khalil Breakdown of academic impact, for papers by Satyamaheshwar Peddibhotla Breakdown of academic impact, for papers by Jens‐Uwe Peters Breakdown of academic impact, for papers by Paolo Di Fruscia Breakdown of academic impact, for papers by Alex S. Kiselyov Breakdown of academic impact, for papers by Mahadevan Lakshminarasimhan
Rankless by CCL
2026